Followers | 401 |
Posts | 17548 |
Boards Moderated | 0 |
Alias Born | 07/14/2003 |
Wednesday, March 31, 2021 9:37:59 AM
Few years ago I did read a reply that the CEO on <<a XY Company>> gave to a shareholder.....It made me Consider that CEO'S are "SENSITIVE and RECEPTIVE"...... They show Appreciation when they are Appreciate!!!.....Respect goes both Way!!!
<<Sent an email to Johnny this morning. He was kind enough to reply and quickly at that.>>
-----------------------------
Thank you sir I really appreciated. These are the kind of things that make me work harder. Taking your time on a Sunday to express your sentiments and what you see. Am not resting till this company becomes a billion dollar Co. Put 8 years of my life into this and failure is not an option. Saw parents and a brother passed a separation and a baby on the way during this Journey. My resume speaks for itself. Since 1991 at 21 years old all i have done is build and enjoy what i do. Haters will always be there. That shows we must be doing something right. Anyone that knows me will tell you Johnny always does what he says he is going to do. Soon or later it will happen. Did you receive your HBO trial?
Thank you from the bottom of my heart.
Johnny ………..
Recent GRST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:45:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:54:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:04:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:55:26 PM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:29:40 PM
- Form 1-A POS - • Edgar (US Regulatory) • 08/29/2023 07:21:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:37:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:43:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 04:51:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 06:56:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM